Nov 6, 2026INVESTMENTChina Zylox-Tonbridge and GL Capital invest HK$1.482B in LifeTech Scientific
Zylox-Tonbridge and GL Capital will jointly invest approximately HK$1.482 billion in LifeTech Scientific for a 16.7% stake. Zylox-Tonbridge will invest HK$889 million and intends to pursue a potential merger with LifeTech.
Productsperipheral vascular devicesneurovascular devicesaortic devicesstructural heart devices
“The investment is expected to bring together Zylox-Tonbridge's peripheral vascular and neurovascular businesses with LifeTech's aortic and structural heart businesses, creating a comprehensive portfolio across four key therapeutic areas.”prnewswire.com
- 3 sources
- prnewswire.comZylox-Tonbridge and GL Capital Announce Strategic Investment in LifeTech Scientific to Build a Leading Vascular and Structural Heart Intervention PlatformZYLOX-TONBRIDGENov 6, 2026
- prnewswire.comZylox-Tonbridge and GL Capital Announce Strategic Investment in LifeTech Scientific to Build a Leading Vascular and Structural Heart Intervention PlatformZYLOX-TONBRIDGENov 6, 2026
- prnewswire.co.ukZylox-Tonbridge and GL Capital Announce Strategic Investment in LifeTech Scientific to Build a Leading Vascular and Structural Heart Intervention PlatformZYLOX-TONBRIDGENov 6, 2026
Summarized from public sources; check the original articles before acting on it.
ENDATA